drugset / Trial / NCT05064345
A Study to Evaluate HB0034 in Healthy Adult Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to investigate the safety and tolerability of HB0034 in healthy subjects following a single dose.
Timeline
- Start
- 2021-12-03
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HB0034 | Monoclonal antibody | — | — |
Indications
No indication recorded.